Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Receivables (2020 - 2025)

IceCure Medical (ICCM) has disclosed Receivables for 6 consecutive years, with $331000.0 as the latest value for Q4 2025.

  • Quarterly Receivables rose 49.77% to $331000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $331000.0 through Dec 2025, up 49.77% year-over-year, with the annual reading at $331000.0 for FY2025, 10933.33% up from the prior year.
  • Receivables for Q4 2025 was $331000.0 at IceCure Medical, up from $221000.0 in the prior quarter.
  • The five-year high for Receivables was $456000.0 in Q4 2021, with the low at $78000.0 in Q4 2022.
  • Average Receivables over 5 years is $237800.0, with a median of $221000.0 recorded in 2024.
  • The sharpest move saw Receivables skyrocketed 385.11% in 2021, then plummeted 82.89% in 2022.
  • Over 5 years, Receivables stood at $456000.0 in 2021, then tumbled by 82.89% to $78000.0 in 2022, then skyrocketed by 32.05% to $103000.0 in 2023, then surged by 114.56% to $221000.0 in 2024, then surged by 49.77% to $331000.0 in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $331000.0, $221000.0, and $103000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.